Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (14067)	11/12/2004 6:55:05 PM
From: The Dodgy Ticker	Read Replies (1) of 52153

Peter, There's some talk about the FDA becoming much more restrictive (i.e., reluctant to approve) new drugs so quickly in the wake of Merck's Vioxx. Do you think that could impact any of the applications you and rkrw are estimating? Disclaimer: I would be crushed if Antegren were delayed. Best regards, Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next